SLC44A2 mediates the VSMC phenotypic switch in aortic aneurysm

(A) The switch from a contractile to a synthetic state is crucial for the development and progression of aortic aneurysm. SLC44A2 functions as a scaffolding protein that regulates the TGF-β/SMAD signaling pathway by forming a complex with NRP1 and ITGB3. This complex facilitates the release of activated TGF-β from latent TGF-β (latency-associated peptide [LAP]), which then binds to TGF-β receptors (TGFBRs) on the cell membrane, initiating the downstream phosphorylation of SMAD2/3. p-SMAD2/3 then translocates into the nucleus, where it regulates the expression of contractile markers ACTA2 and TAGLN, or synthetic markers KLF4 and OPN, associated with the VSMC phenotypic switch. SLC44A2 deficiency induced by siSLC44A2 disrupts the association between NRP1 and ITGB3, reduces the levels of TGF-β and p-SMAD2, and promotes the expression of synthetic VSMC markers KLF4 and OPN, while suppressing contractile VSMC markers ACTA2 and TAGLN, further contributing to the pathogenesis of aortic aneurysm. (B) RUNX1 acts as a key regulator of SLC44A2 by binding to the SLC44A2 promoter region and transcriptionally activating SLC44A2 gene expression. Lenalidomide (LEN), an activator of RUNX1, enhances SLC44A2 expression, boosting the SLC44A2/NRP1/ITGB3/TGF-β/SMAD signaling pathway. This promotes the expression of VSMC contractile markers ACTA2 and TAGLN, and represses synthetic VSMC markers KLF4 and OPN, inhibiting the phenotypic switching of VSMCs from a contractile to a synthetic state, ultimately suppressing the development of aortic aneurysm
SLC44A2 mediates the VSMC phenotypic switch in aortic aneurysm

Publication

SLC44A2-mediated phenotypic switch of vascular smooth muscle cells contributes to aortic aneurysm (2024) Mengen Xing, et al. J Clin Invest. 2024 Aug 15;134(16). Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates LAP LAP ncbigene_symbol LAP 7939
Homo sapiens Primates LAP LAP ncbigene_synonym ACP2 53
Homo sapiens Primates LAP LAP ncbigene_synonym TGFB1 7040
Homo sapiens Primates LAP LAP ncbigene_synonym PICALM 8301
Homo sapiens Primates LAP LAP ncbigene_synonym LAP3 51056
Homo sapiens Primates LAP LAP ncbigene_synonym CENPJ 55835
Homo sapiens Primates LAP LAP ncbigene_synonym PDON2 406237
Homo sapiens Primates ITGB3 ITGB3 ncbigene_symbol ITGB3 3690
Homo sapiens Primates NRP1 NRP1 ncbigene_symbol NRP1 8829
Homo sapiens Primates NRP1 NRP1 ncbigene_synonym NELL1 4745
Homo sapiens Primates SLC44A2 SLC44A2 ncbigene_symbol SLC44A2 57153
Homo sapiens Primates TGF-B TGFB famplex_relations TGFB2 7042
Homo sapiens Primates TGF-B TGFB famplex_relations TGFB3 7043
Homo sapiens Primates TGFBR TGFBR famplex_relations TGFBR1 7046
Homo sapiens Primates TGFBR TGFBR famplex_relations TGFBR2 7048
Homo sapiens Primates TGFBR TGFBR famplex_relations TGFBR3 7049
Homo sapiens Primates p-SMAD2/3 SMAD3 ncbigene_symbol SMAD3 4088
Homo sapiens Primates p-SMAD2/3 SMAD2 ncbigene_symbol SMAD2 4087
Homo sapiens Primates ↓ACTA2 ACTA2 ncbigene_symbol ACTA2 59
Homo sapiens Primates TAGLN TAGLN ncbigene_symbol TAGLN 6876
Homo sapiens Primates KLF4 KLF4 ncbigene_symbol KLF4 9314
Homo sapiens Primates OPN OPN ncbigene_synonym SPP1 6696
Homo sapiens Primates RUNX1 RUNX1 ncbigene_symbol RUNX1 861

Chemical mentions

Word Match MeSH Name ChEBI
Nucleus nucleus nucleus chebi:33252
Lenalidomide lenalidomide 3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione chebi:63791

Disease mentions

Word Match MeSH Name DOID